Literature DB >> 16920921

T helper lymphocytes rescue CTL from activation-induced cell death.

Richard Kennedy1, Esteban Celis.   

Abstract

T cell activation is characterized by a vast expansion of Ag-specific T cells followed by an equally extensive reduction in T cell numbers. This decline is due, in part, to activation-induced apoptosis of the responding T cells during repeated encounter with Ag. In the current study, we used solid-phase MHC class I/peptide monomers to cause activation-induced cell death (AICD) of previously activated CD8 T cells in an Ag-specific manner. AICD occurred rapidly and was mediated primarily by Fas-FasL interactions. Most interestingly, we observed that Th cells could provide survival signals to CTL significantly reducing the level of AICD. Both Th1 and Th2 subsets were capable of protecting CTL from AICD, and a major role for soluble factors in this protection was ruled out, as cell-to-cell contact was an essential component of this Th-mediated protection. Upon encounter with Ag-expressing tumor cells, CTL underwent significant apoptosis. However, in the presence of Th cells, the CTL not only were protected against death, but also had significantly greater lytic ability. In vivo tumor protection studies using peptide immunization showed that the activation of Ag-specific Th cells was crucial for optimal protection, but did not affect the magnitude of the CTL response in the lymphoid tissues. In this study, we examine the type of help that CD4 T cells may provide and propose a model of Th cell-CTL interaction that reduces CTL death. Our results show a novel role for Th cells in the maintenance of CTL responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920921      PMCID: PMC1594817          DOI: 10.4049/jimmunol.177.5.2862

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligation.

Authors:  Xue-Zhong Yu; Paul J Martin; Claudio Anasetti
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 2.  IL-7, the thymus, and naïve T cells.

Authors:  Yukari Okamoto; Daniel C Douek; Richard D McFarland; Richard A Koup
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

3.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

4.  CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Yasushi Cho; Masaki Miyamoto; Kentaro Kato; Akira Fukunaga; Toshiaki Shichinohe; You Kawarada; Yasuhiro Hida; Taro Oshikiri; Takanori Kurokawa; Masato Suzuoki; Yoshihiro Nakakubo; Kei Hiraoka; Soichi Murakami; Toshiya Shinohara; Tomoo Itoh; Shunichi Okushiba; Satoshi Kondo; Hiroyuki Katoh
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

5.  T cells use two directionally distinct pathways for cytokine secretion.

Authors:  Morgan Huse; Björn F Lillemeier; Michael S Kuhns; Daniel S Chen; Mark M Davis
Journal:  Nat Immunol       Date:  2006-01-29       Impact factor: 25.606

6.  Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.

Authors:  Vera Sobek; Sandra Balkow; Heinrich Körner; Markus M Simon
Journal:  Eur J Immunol       Date:  2002-09       Impact factor: 5.532

7.  T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.

Authors:  Wendy F Davidson; Christian Haudenschild; Jaeyul Kwon; Mark S Williams
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

8.  Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim.

Authors:  Gayle M Davey; Christian Kurts; Jacques F A P Miller; Philippe Bouillet; Andreas Strasser; Andrew G Brooks; Francis R Carbone; William R Heath
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

9.  Interferon gamma is required for activation-induced death of T lymphocytes.

Authors:  Yosef Refaeli; Luk Van Parijs; Stephen I Alexander; Abul K Abbas
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

10.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

View more
  22 in total

1.  Distinctive in vitro effects of T-cell growth cytokines on cytomegalovirus-stimulated T-cell responses of HIV-infected HAART recipients.

Authors:  Julie Patterson; Renee Jesser; Adriana Weinberg
Journal:  Virology       Date:  2008-06-24       Impact factor: 3.616

2.  Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations.

Authors:  Zhaoting Meng; Yadong Wang; Guanzhong Zhang; Yuehua Ke; Yanfeng Yan; Liangliang Wu; Qianrong Huang; Gang Zeng; Yu Wang; Han Ying; Shunchang Jiao
Journal:  J Immunother       Date:  2011-09       Impact factor: 4.456

3.  Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection.

Authors:  Patricia Novy; Xiaopei Huang; Warren J Leonard; Yiping Yang
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

Review 4.  Personalized peptide vaccines and their relation to other therapies in urological cancer.

Authors:  Takahiro Kimura; Shin Egawa; Hirotsugu Uemura
Journal:  Nat Rev Urol       Date:  2017-05-31       Impact factor: 14.432

5.  Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.

Authors:  Victoria M Velazquez; David G Bowen; Christopher M Walker
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

6.  Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.

Authors:  Takumi Kumai; Sujin Lee; Hyun-Il Cho; Hussein Sultan; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

7.  In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.

Authors:  Deepak Assudani; Hyun-Il Cho; Nicholas DeVito; Norma Bradley; Esteban Celis
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

8.  Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.

Authors:  Li-Xin Wang; Suyu Shu; Mary L Disis; Gregory E Plautz
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

9.  Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells.

Authors:  Zuqiang Liu; Hae S Noh; Janet Chen; Jin H Kim; Louis D Falo; Zhaoyang You
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 10.  Peptide epitope identification for tumor-reactive CD4 T cells.

Authors:  Hiroya Kobayashi; Esteban Celis
Journal:  Curr Opin Immunol       Date:  2008-05-20       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.